(Q34994544)

5 August 2017

0 references

1 reference

title

Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis (English)

1 reference

5 August 2017

0 references

0 references

1 reference

Jose Sanchez-Moreno

2

0 references

Ferran Torres

object named as

Ferran Torres

3

0 references

Eduard Vieta

object named as

Eduard Vieta

6

0 references

author name string

Nuria Cruz

1

1 reference

5 August 2017

Jose Manuel Goikolea

4

1 reference

5 August 2017

Marc Valentí

5

1 reference

5 August 2017

publication date

29 July 2009

1 reference

The International Journal of Neuropsychopharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

5-14

1 reference

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Characterizing barriers, challenges and unmet needs in the management of bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Role of aripiprazole in treating mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Clinical correlates of first-episode polarity in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Clinical and therapeutic implications of predominant polarity in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Practice guideline for the treatment of patients with bipolar disorder (revision)

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Bipolar depression: phenomenological overview and clinical characteristics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Diagnostic guidelines for bipolar depression: a probabilistic approach

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709990344

7 January 2021

10.1017/S1461145709990344

Identifiers

DOI

1 reference

5 August 2017

1 reference